Showing 851-860 of 1328 results for "".
Post-Traumatic Stress Disorder Following TBI and the Neurologic-Psychiatric Borderland
https://practicalneurology.com/diseases-diagnoses/tbi/post-traumatic-stress-disorder-following-tbi-and-the-neurologic-psychiatric-borderland/30385/Increasing data suggest an overlap of neurologic and psychiatric elements in traumatic brain injury.Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury-1/32192/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.Neuromuscular Notes: New and Emerging Therapies in ALS
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-new-and-emerging-therapies-in-als/32007/New therapies—including antisense oligonucleotides, mesenchymal stem cells, and kinase inhibitors—are in development to target specific pathogenic mechanisms identified in ALS.Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/imaging-testing/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury/32184/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.Dystrophinopathies and the Limb-Girdle Muscular Dystrophies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/dystrophinopathies-and-the-limb-girdle-muscular-dystrophies/32028/Disease management for dystrophinopathies and limb-girdle muscular dystrophies has evolved from palliation to genetic therapeutics, paving the way toward a cure.Doctors Betrayed by Traditional Financial Strategies: Part 1 of 2
https://practicalneurology.com/columns/practice-management/doctors-betrayed-by-traditional-financial-strategies-part-1-of-2/30456/The financial challenges and risks physicians face are unique and therefore demand specialized guidance and advice.Doctors Betrayed By Traditional Financial Strategies, Part 2 of 2
https://practicalneurology.com/columns/practice-management/doctors-betrayed-by-traditional-financial-strategies-part-2-of-2/30446/Migraine Preventive Therapies
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-preventive-therapies/31511/With new—and first-in-class—migraine-specific treatments, preventive treatment of migraine is changing quickly.Self-Limited Focal Epilepsies in Childhood
https://practicalneurology.com/diseases-diagnoses/child-neurology/self-limited-focal-epilepsies-in-childhood/30186/Recent advances improve understanding of etiology, clinical and EEG findings, and clinical management for this category that comprises 20% of pediatric epilepsies.Preferred Treatment: The Changing Economics of Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/preferred-treatment-the-changing-economics-of-multiple-sclerosis-care/30486/By deciding which drugs are “preferred,” insurance companies are reducing the practice of evidence-based medicine to a series of economic choices.